Guidepoint Qsight captured insights into the overall U.S. Orthopedics Knee market, identifying tremendous double-digit growth in Q2 2021, up 13.5% from Q1 2021.
Although Zimmer Biomet reported sequential growth (+11.6%) for the U.S. Orthopedic Knee market, Qsight data indicates a loss of share in Q2 2021, marking the second consecutive quarter that Zimmer Knee has lost ground to its’ competitors.
Looking ahead to Q3 2021, we surveyed a panel of physicians to gather their outlook on market growth and manufacturer share expectations. Despite expecting a 5.3% growth in the U.S. Orthopedic Knee market, all signs point to Zimmer losing unit-share once again.
Despite uncertainty in elective procedure volumes as COVID-19 Delta variant cases surge, all eyes will be on Zimmer Knee performance in the second half of 2021.
For more insights into expected growth rates and unit-share shifts among key MedTech markets and manufacturers, view our recent TRACKER Alerts here.
Post created by: Sean Sookhoo, Vice President of Market Research, Ariana Tsanas, Research Operations Analyst, Skylar Gross, Healthcare Analyst, and Shimul Sheth, Senior Quantitative Analyst